Abstract Background Glioblastoma (GBM) is the most common brain tumor with the worst prognosis. Temozolomide is the only first-line drug for GBM. Unfortunately. the resistance issue is a classic problem. https://www.darthomes.shop/product-category/organization/
AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway
Internet 23 hours ago adollpovqx3fas
Web Directory Categories
Web Directory Search
New Site Listings